Pfizer-BioNTech claimed that the Covid-19 vaccine produces a strong immune response in children aged between five to eleven years old. Pfizer Inc and BioNTech SE said they are planning to ask the government to roll out the vaccine for this particular age group as soon as possible. Health Minister Khairy Jamaluddin will announce PPVs for walk-in Covid vaccine today for children.
Follow MyShorts, News In 60 Words
The companies said they have compared the safety profile to the older age group and it matches the clinical trial results. The vaccine creates an immune response in 5 to 11-year-old children in their Phase 2/3 clinical trial.
Pfizer chief executive Albert Bourla said the clinical trial results have provided the foundation to get authorisation for the vaccine for children aged between 5-11. He also said that the companies are planning to submit the plan to the FDA and other regulators as soon as possible.
He stated that since July, the rate of Covid-19 cases in kids, has increased to 240% in the United States, calling for vaccination. Authorities will give the green light to vaccine roll out after top US health officials decide whether it is safe for children or not, within three weeks time period.